| CAS ID: | 185913-78-4 |
| Molecular Formula: | C33H45N3O7S |
| Molecular Weight: | 627.8 g/mol |
| Monoisotopic Mass: | 627.2978 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | SR121463F | Aquilda | SATAVAPTAN | SR121463 | SR121463B | SR 121463A |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C33H45N3O7S/c1-6-43-25-8-9-27-26(22-25)33(14-11-23(12-15-33)13-16-35-17-19-42-20-18-35)31(38)36(27)44(39,40)29-10-7-24(21-28(29)41-5)30(37)34-32(2,3)4/h7-10,21-23H,6,11-20H2,1-5H3,(H,34,37)/t23-,33+ | See All |
| InChI Key: | CDSBFDCCJJDFCV-CKZSCMLPSA-N | |
| Smiles: | CCOc1ccc2N(C(=O)[C@@]3(CC[C@H](CCN4CCOCC4)CC3)c2c1)S(=O)(=O)c5ccc(cc5OC)C(=O)NC(C)(C)C | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00366795 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Terminated |
| First Received | August 21, 2006 | Last Verified | May 18, 2016 |
| Sponsor | Sanofi | ||
Trial Record 2
| ClinicalTrial ID | NCT00359437 | Disease | Liver fibrosis |
| Phase | Phase 3 | Status | Terminated |
| First Received | August 2, 2006 | Last Verified | May 24, 2016 |
| Sponsor | Sanofi | ||
| PubChem: | 158348 |
| ChEMBL: | CHEMBL2107777 |